Biogen Inc.
BIIB Healthcare Drug Manufacturers General
Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow BIIB
Biogen Inc. (BIIB) Net margin
Biogen Inc.'s net margin over the twelve months to 30 June 2026 was 8.32%, down 4.8 percentage points from fiscal 2025 (13.1%). Over the past ten years it has ranged from 11.8% (fiscal 2023) to 41.0% (fiscal 2019); the current reading is higher than 18% of that period. That is in line with the Drug Manufacturers General industry median of 8.27% and above the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | 13.1% | (3.80) |
| FY2024 | 16.9% | 5.06 |
| FY2023 | 11.8% | (18.14) |
| FY2022 | 30.0% | 15.78 |
| FY2021 | 14.2% | (15.59) |
| FY2020 | 29.8% | (11.20) |
| FY2019 | 41.0% | 8.03 |
| FY2018 | 32.9% | 12.24 |
| FY2017 | 20.7% | (11.65) |
| FY2016 | 32.3% | (0.61) |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Jun 2026 | 3.56% | (9.33) |
| Mar 2026 | 12.9% | 15.04 |
| Dec 2025 | −2.15% | (20.55) |
| Sep 2025 | 18.4% | (5.60) |
| 42 more quarters | Free account |
Against its own ten years
Net margin against peers
| Company | Net margin |
|---|---|
| NVO Novo Nordisk A/S compare | 35.5% |
| AMGN Amgen Inc. compare | 23.0% |
| BMY Bristol Myers Squibb Company compare | 18.9% |
| AZN AstraZeneca PLC compare | 17.0% |
| GSK GSK PLC Sponsored ADR compare | 14.6% |
| BIIB Biogen Inc. | 8.32% |
| SNY Sanofi compare | 8.22% |
| PFE Pfizer Inc. compare | 6.80% |
| GILD Gilead Sciences, Inc. compare | −10.6% |
| Drug Manufacturers General industry median | 8.27% |
| Healthcare sector median | 0.00% |
| Market median | 0.45% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on BIIB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement